课题基金 / 基金详情

Metabolism during the Progression of Photoreceptor Degeneration

Metabolism during the Progression of Photoreceptor Degeneration
感光器退化过程中的代谢
批准号:
10638849
负责人:
Daniel T Hass
金额:
$11.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-01 至 2025-05-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract Retinitis pigmentosa (RP) is an inherited, early-onset, and irreversible form of vision loss. RP can result from mutations in over 100 unique genes. The burden of developing individualized treatments for each mutation is high, so strategies that improve photoreceptor health regardless of mutation would be benefit patients. RP perturbs retina energy metabolism, and disrupted energy metabolism can cause degeneration. Metabolic reprogramming may prevent photoreceptor loss. Reprogramming efforts should be aimed at correcting changes that occur with RP, yet it is unclear which changes to correct. In RP there are disruptions in glucose transport, aerobic glycolysis and the normal expression of TCA cycle and pentose phosphate pathway (PPP) genes. Due to critical gaps in these studies, the nature and timing of these changes is unclear. The lack of comprehensive detail on how RP alters metabolic flux hampers efforts to protect photoreceptors. The aims of this application are aimed at understanding changes to metabolism in RP. Specifically, in aim 1 I will determine how the rate of metabolism changes with disease stage. I will infuse 13C-labeled glucose or lactate through catheters to probe flux of carbons through metabolic pathways in the retina and RPE-choroid. I will quantify 13C accumulation in metabolites of glycolysis, the TCA cycle, the PPP, gluconeogenesis, and glycogen. Metabolites that fuel these pathways must first be transported from circulation, through the retinal pigment epithelium (RPE), and to the retina. In Aim 2 I will determine metabolites that increase O2 consumption by ex vivo RPE-choroid, and which of these best labels intermediates in the RPE-choroid in vivo. This proposal also seeks support for my career development. My development goals include presenting my work at conferences and leveraging these presentations to form a scientific network. I will also take scientific and non-scientific courses to improve my ability to perform surgeries and mentor young scientists. These opportunities will prepare me for a position as an independent investigator, where I can continue to fulfill the aims of this proposal and further develop my research program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: